PP_1170x120_10-25-21

Skintelli

EpigenCare launches limited beta release of its personal epigenetic skin care test

EpigenCare launches limited beta release of its personal epigenetic skin care test

FARMINGDALE, N.Y. — EpigenCare Inc., a biotechnology company focused on consumer epigenetics, publicly launched Tuesday its beta-stage product for personalized skincare called Skintelli (https://www.skintelli.com/). The product is the first direct-to-consumer epigenetic test on the market to assess the dynamic qualities of a consumer’s skin. Skintelli specifically looks at a panel of epigenetic marks that determine the